This will be a live conversation about clinical trials and MS – how to get into one and their risks and benefits. Bruce will discuss the clinical trial landscape for both relapsing/remitting and progressive forms of MS. I'll describe my experiences in 2005 and 2006 when I participated in a clinical trial for a drug called Rituxan. To read my blog posts about that trial, click here.
There are limited slots available, so if you would like to watch the webinar, live, register using this link. Time permitting, we'll take questions from the audience.